期刊文献+

他克莫司治疗儿童难治性肾病综合征临床疗效分析 被引量:6

下载PDF
导出
摘要 目的:探讨他克莫司(FK506)治疗儿童难治性肾病综合征的临床疗效.方法:选择住院难治性肾病综合征患儿40例,随机分为治疗组(A组)和对照组(B组)各20例,两组均予泼尼松1~1.5 mg/(kg·d)口服,A组予FK506治疗,B组予环磷酰胺(CTK)治疗.结果:A组总有效率90.0%,B组总有效率65.0%,差异有统计学意义(χ2=23.12,P<0.01).A组治疗6个月后尿蛋白定量下降程度及血清白蛋白升高程度均优于B组(P<0.01),差异有统计学意义.结论:FK506是治疗儿童难治性肾病综合征有效药物,具有起效早、恢复快、缓解率高特点.
出处 《吉林医学》 CAS 2014年第8期1628-1630,共3页 Jilin Medical Journal
  • 相关文献

参考文献6

  • 1Chen M,Li H,Li X Y,et al.Tacrolimus combined with corticosteroids in treatment of nephtotic idiopathic membranous nephropathy:a multicenter randomized controlled trail[J].Am J Med Sci,2010,339(3):233.
  • 2中华医学会儿科学分会肾脏病学组,姚勇,杨霁云,陈述枚,丁洁.小儿肾小球疾病的临床分类、诊断及治疗[J].中华儿科杂志,2001,39(12):746-749. 被引量:1530
  • 3Siha MD,Macleod R,RigbyE,et al.Treatment of severe steroid-dependent nephrotic syndrome(SDNS)in children with tacrolimus[J].Nephrol Dial Transplant,2006,21(7):1848.
  • 4Choudh S,Bagga A,Hari P,et al.Efficacy and safety of Tacrolimus versus cyclosporine in children with steroid-resistant nephrotic syndrome:a randmized controlled trial[J].Am J Kidey Dis,2009,53(5):760.
  • 5Culati S,Prasad N,Sharma RK,et al.Tacrolimus:a new therapy for steroid-resistant nephritic syndrome inchildren.Nephrol Dial Transplant,2008,23(3):910.
  • 6李红梅,施向东.他克莫司治疗激素抵抗性肾病综合征[J].实用医学杂志,2009,25(22):3871-3873. 被引量:18

二级参考文献5

  • 1Westhoff T H.van der Giet M.Tacrolimus in the treatment of idiopathic nephrotic syndrome[J].Expert Opin Investig Drugs,2007,16(7):1099-1110.
  • 2Habashy D,Hodson E M,Craig J C.Interventions for steroidresistant nephrotic syndrome:a systematic review[J].Pediatr Nephrol,2003,18(9):906-912.
  • 3Loeffler K,Gowrishankar M,Yiu V.Tacrolimus therapy in pediatric patients with treatment-resistant nephrotic syndrome[J].Pediatr Nephrol,2004,19(3):281-287.
  • 4Butani L,Ramsamooj R.Experience with tacrolimus in children with steroid-resistant nephrotic syndrome[J].Pediatr Nephrol,2009,24(8):1517-1523.
  • 5孙广东,许钟镐,罗萍,苗里宁.他克莫司联合小剂量激素治疗特发性膜性肾病的疗效观察[J].中国实用内科杂志,2008,28(7):542-545. 被引量:15

共引文献1543

同被引文献58

  • 1牟燕,李元媛,林琳,王鹏.合并用药对环孢素A血药浓度的影响[J].中国药物应用与监测,2006,3(1):20-22. 被引量:9
  • 2朱承栋,陈朝霞.激素治疗小儿原发性肾病综合征对淋巴细胞产生的影响分析[J].中国医学前沿杂志(电子版),2014,6(2):63-66. 被引量:3
  • 3关欣,郑红光.霍平,等.他克莫司对难治性肾病综合征患者临球肾炎[J].肾脏病与透析肾移植杂志,2012,21(3):260-267.
  • 4李世军.改善全球肾脏病预后组织(KDIGO)临床实践指南:肾床疗效的影响[J].贵阳医学院学报,2012,37(5):535-537.
  • 5Hodson EM, WillisoNS, Craig JC. Interventions for idiopathic ste mid-resistant nephrotie syndrome in children. Cochrane Database Systematic Reviews, 2010, Issue 11 : 1-89.
  • 6Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA Statement for'Reporting Systematic Reviews and Meta- Analyses of Studies That Evaluate Health Care Interventions : Expla nation and Elaboration[J]. Annals of Internal Medicine, 2009, 151 (4) :65-94.
  • 7Hartling L, Ospina M, Liang Y, et al. Risk of bias versus quality assessment of randomised controlled trials[J] : cross sectional study. BMJ, 2009, 339:h4012.
  • 8Schulz KF, Altman DG, Moher D; CONSORT Grp. CONSORT 2010 Statement : [J]update guidelines for reporting parallel group randomised trials. Trials, 2010, 11 : 32.
  • 9Deeks JJ, Higgins JPT, Altman DG (editors). Chapter 9: Analys ing data and undertaking meta-analyses. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Inter y~entions Version 5.0.0 (updated February 2008). [J]The Cochrane Collaboration, 2008. Available from: http://www. Cochrane-hand.
  • 10Gulati A, Sinha A, Gupta A, et al. Treatment with taerolimus and prednisolone is preferable to intravenous eyclophosphamide as the initial therapy for children with steroid-resistant nephrotic syndrome[J]. Kidney International, 2012, 82(10) : 1130-1135.

引证文献6

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部